OTC · Biotechnology

Orgenesis Inc. (ORGS) Stock

$0.11 -72.50% OTC: ORGS Healthcare

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies.

Valuation

MetricValue
Price$0.11
Market Cap$568618
P/E Ratio-0.06
P/B Ratio-0.15
P/S Ratio1.07
EPS (TTM)$-1.91
52-Week High$5.89
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE261.90%
ROA-380.44%
ROCE5400.00%
Gross Margin-5300.00%
Operating Margin-5400.00%
Net Margin-5500.00%
Debt/Equity-1.08
Current Ratio0.25

Annual Financials (USD)

Metric20192020202120222023
Revenue$33.0M$8.0M$36.0M$36.0M$1.0M
Operating Profit$-25.0M$-96.0M$-17.0M$-8.0M$-54.0M
Net Profit$-26.0M$-96.0M$-18.0M$-15.0M$-55.0M
EPS$-1.64$-4.46$-0.74$-0.59$-1.91
Op Margin-74.0%-1251.7%-47.3%-20.9%-10120.0%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$92.0M$78.0M$60.0M$91.0M$15.0M
Total Liabilities$86.0M$25.0M$21.0M$32.0M$36.0M
Cash$11.0M$45.0M$5.0M$5.0M$1.0M
Borrowings$25.0M$13.0M$12.0M$20.0M$23.0M

Latest News

Atombit Signs Medallia Alliance to Generate Measurable Outcomes with AI-Driven Experience Intelligence PR Newswire · Jul 23, 2026 INTURAI HOSTS INVESTOR CALLS TODAY WITH PLATFORM DEMONSTRATIONS PR Newswire · Jul 23, 2026 Can an Aging America Escape the Nursing Home Default? "All Access hosted by Andy Garcia" Features Northland PACE Senior Care Services PR Newswire · Jul 23, 2026 IDnow Appoints Philippe Morel as Chief Executive Officer PR Newswire · Jul 23, 2026 ARTHEx Biotech Publishes First Demonstration of Improvement in a DM1-related Behavioral Alteration in a Preclinical Model of Myotonic Dystrophy Type 1 (DM1) PR Newswire · Jul 23, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-13.0M$-78.0M$-27.0M$-25.0M$-15.0M
Investing Cash Flow$-26.0M$104.0M$-20.0M$-27.0M$-7.0M
Financing Cash Flow$13.0M$0$-1.0M$21.0M$5.0M
Net Cash Flow$-3.0M$34.0M$-40.0M$0$-5.0M
Free Cash Flow$-25.0M$-80.0M$-35.0M$-37.0M$-17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.37
FCF Yield-2977.92%
Quick Ratio0.25
Interest Coverage-24.75
Return 1Y-60.40%
Return 3Y-96.33%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BPTHBio-Path Holdings, Inc. $0.04 +0.00% -0.05 $355002 0.00%
EMMAEmmaus Life Sciences, Inc. $0.01 +0.09% -0.09 $824010 0.00%
HXBMHelix BioMedix, Inc. $1.02 +0.00% -0.42 $229202 0.00%
IDCNIndocan Resources Inc. $0.00 — — $74079 0.00%
NGMCNext Generation Management Corp. $0.10 +0.00% 0.00 $31163 0.00%

About Orgenesis Inc.

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.

Orgenesis Inc. is headquartered in US.

Orgenesis Inc. (ORGS) stock trades at $0.11 with a market capitalization of $568618. The stock is valued at a price-to-earnings (P/E) ratio of -0.06, price-to-book of -0.15, price-to-sales of 1.07. Over the past 52 weeks the stock has ranged between $0.02 and $5.89, and currently trades 98.1% below its 52-week high.

On profitability, Orgenesis Inc. generates a return on equity (ROE) of 261.90% — well above the market average, a sign of a high-quality business, return on capital employed of 5400.00%, an operating margin of -5400.00%, a net profit margin of -5500.00%.

Official website: www.orgenesis.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides